Adverse events168

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

61 to 80 of 168

Type	Event	Organ system	Group	Affected	At risk
serious	Malignant Melanoma in Situ	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% & Placebo	1	251
serious	Malignant Melanoma in Situ	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Malignant Melanoma in Situ	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% BID	0	253
serious	Myelodysplastic Syndrome	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% & Placebo	1	251
serious	Myelodysplastic Syndrome	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Myelodysplastic Syndrome	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% BID	0	253
serious	Prostate Cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% & Placebo	1	251
serious	Prostate Cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Prostate Cancer	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	AR-13324 Ophthalmic Solution 0.02% BID	0	253
serious	Foot Fracture	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% & Placebo	0	251
serious	Foot Fracture	Injury, poisoning and procedural complications	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Foot Fracture	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% BID	1	253
serious	Postoperative Ileus	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% & Placebo	1	251
serious	Postoperative Ileus	Injury, poisoning and procedural complications	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Postoperative Ileus	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% BID	0	253
serious	Road Traffic Accident	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% & Placebo	0	251
serious	Road Traffic Accident	Injury, poisoning and procedural complications	Timolol Maleate Ophthalmic Solution 0.5% BID	0	251
serious	Road Traffic Accident	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% BID	1	253
serious	Fall	Injury, poisoning and procedural complications	AR-13324 Ophthalmic Solution 0.02% & Placebo	0	251
serious	Fall	Injury, poisoning and procedural complications	Timolol Maleate Ophthalmic Solution 0.5% BID	1	251

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02207621/events?page=4

API reference For AI assistants